COVID19 associated pulmonary aspergillosis
The novel coronavirus (COVID-19) pandemic announced by the World Health Organization in March 2020 assigned medical community to the new tasks that require immediate solutions. Recent studies have shown that invasive aspergillosis associated with COVID-19 often complicates a course of the disease an...
Main Authors: | Ovsyannikov N.V., Bilevich O.A. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2021-09-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2021/3/cmac-2021-t23-n3-p239/cmac-2021-t23-n3-p239.pdf |
Similar Items
-
COVID-19 Associated Pulmonary Aspergillosis: A Case Series
by: Mira Yulianti, et al.
Published: (2022-04-01) -
COVID-19-Associated Pulmonary Aspergillosis in Russia
by: Olga Shadrivova, et al.
Published: (2021-12-01) -
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
by: Andre K. Johnson, et al.
Published: (2021-06-01) -
COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges
by: Aia Mohamed, et al.
Published: (2020-07-01) -
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
by: Matthias Egger, et al.
Published: (2022-04-01)